NASDAQ · Analyst Forecast

Unicycive Therapeutics, Inc. (UNCY) Stock Forecast & Price Target

$3.70 NASDAQ: UNCY Market Cap $103.06M

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 18, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Unicycive Therapeutics, Inc. (UNCY), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Unicycive Therapeutics, Inc., analysts forecast revenue rising from $517,000 in 2025 to $407.33M in 2030; the average estimate for 2030 earnings per share is $5.42; with published estimates ranging from $0.70 to $11.83; 7 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$3.70
Consensus targetThe average of the price targets analysts have published.$22.00
Median targetThe middle target, less affected by a single outlier.$22.00
Highest targetThe most optimistic published target.$22.00
Lowest targetThe most pessimistic published target.$22.00
Difference from priceHow far the consensus target sits from today’s price.+494.6%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$170,501$517,000$986,5715
2026$421,397$1.28M$2.44M5
2027$17.73M$90.53M$198.38M6
2028$208.45M$496.31M$964.50M7
2029$147.67M$447.76M$854.44M3
2030$134.33M$407.33M$777.30M5

Earnings per share forecast

YearLowAverageHighAnalysts
2025−$1.51−$1.43−$1.355
2026−$1.53−$1.24−$0.665
2027−$0.37$0.63$2.416
2028$2.84$7.17$13.907
2029$0.83$6.41$13.983
2030$0.70$5.42$11.835

Unicycive Therapeutics, Inc. (UNCY) forecast — frequently asked questions

What is the analyst price target for Unicycive Therapeutics, Inc.?

Analysts covering Unicycive Therapeutics, Inc. (UNCY) have a consensus price target of $22.00, 494.6% above the current price of $3.70. Published targets range from $22.00 to $22.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Unicycive Therapeutics, Inc.'s earnings?

The average analyst estimate for Unicycive Therapeutics, Inc. (UNCY) earnings per share in 2030 is 5.42, with individual estimates between 0.70 and 11.83.

How much revenue is Unicycive Therapeutics, Inc. expected to make?

Analysts forecast Unicycive Therapeutics, Inc. (UNCY) revenue of $407.33M in 2030, based on 5 published estimates.

How many analysts cover UNCY?

7 analysts contribute estimates for Unicycive Therapeutics, Inc. (UNCY). Thin coverage makes an average less reliable.

Analyst forecasts for other Biotechnology stocks

VRTX forecastREGN forecastMRNA forecastRVMD forecastROIV forecastINSM forecastUTHR forecastINCY forecastALNY forecastASND forecastAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.